» Articles » PMID: 24834013

The Rat Striatum Responds to Nigro-striatal Degeneration Via the Increased Expression of Proteins Associated with Growth and Regeneration of Neuronal Circuitry

Overview
Journal Proteome Sci
Publisher Biomed Central
Date 2014 May 17
PMID 24834013
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Idiopathic Parkinson's disease is marked by degeneration of dopamine neurons projecting from the substantia nigra to the striatum. Although proteins expressed by the target striatum can positively affect the viability and growth of dopaminergic neurons, very little is known about the molecular response of the striatum as nigro-striatal denervation progresses. Here, iTRAQ labelling and MALDI TOF/TOF mass spectrometry have been used to quantitatively compare the striatal proteome of rats before, during, and after 6-OHDA induced dopamine denervation.

Results: iTRAQ analysis revealed the differential expression of 50 proteins at 3 days, 26 proteins at 7 days, and 34 proteins at 14 days post-lesioning, compared to the unlesioned striatum. While the denervated striatum showed a reduced expression of proteins associated with the loss of dopaminergic input (e.g., TH and DARPP-32), there was an increased expression of proteins associated with regeneration and growth of neurites (e.g., GFAP). In particular, the expression of guanine deaminase (GDA, cypin) - a protein known to be involved in dendritic branching - was significantly increased in the striatum at 3, 7 and 14 days post-lesioning (a finding verified by immunohistochemistry).

Conclusions: Together, these findings provide evidence to suggest that the response of the normal mammalian striatum to nigro-striatal denervation includes the increased expression of proteins that may have the capacity to facilitate repair and growth of neuronal circuitry.

Citing Articles

AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/- spinal muscular atrophy mice.

Brown S, Soltic D, Synowsky S, Shirran S, Chilcott E, Shorrock H Hum Mol Genet. 2023; 32(20):2950-2965.

PMID: 37498175 PMC: 10549791. DOI: 10.1093/hmg/ddad121.


The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo.

Ledahawsky L, Terzenidou M, Edwards R, Kline R, Graham L, Eaton S FEBS J. 2022; 289(13):3894-3914.

PMID: 35092170 PMC: 9542548. DOI: 10.1111/febs.16377.


Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease.

Dakik H, Mantash S, Nehme A, Kobeissy F, Zabet-Moghaddam M, Mirzaei P Front Neurosci. 2021; 15:621121.

PMID: 33776636 PMC: 7991918. DOI: 10.3389/fnins.2021.621121.


Lamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy.

Soltic D, Shorrock H, Allardyce H, Wilson E, Holt I, Synowsky S Hum Mol Genet. 2019; 28(21):3515-3527.

PMID: 31397869 PMC: 6927462. DOI: 10.1093/hmg/ddz195.


Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice.

Kline R, Dissanayake K, Hurtado M, Martinez N, Ahl A, Mole A Neurobiol Dis. 2019; 130:104496.

PMID: 31176719 PMC: 6704473. DOI: 10.1016/j.nbd.2019.104496.


References
1.
Sharma K, Selzer M, Li S . Scar-mediated inhibition and CSPG receptors in the CNS. Exp Neurol. 2012; 237(2):370-8. PMC: 5454774. DOI: 10.1016/j.expneurol.2012.07.009. View

2.
Outeiro T, Kontopoulos E, Altmann S, Kufareva I, Strathearn K, Amore A . Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 2007; 317(5837):516-9. DOI: 10.1126/science.1143780. View

3.
Geisler S, Holmstrom K, Skujat D, Fiesel F, Rothfuss O, Kahle P . PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010; 12(2):119-31. DOI: 10.1038/ncb2012. View

4.
Rolls A, Shechter R, Schwartz M . The bright side of the glial scar in CNS repair. Nat Rev Neurosci. 2009; 10(3):235-41. DOI: 10.1038/nrn2591. View

5.
Choi P, Snyder H, Petrucelli L, Theisler C, Chong M, Zhang Y . SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res. 2003; 117(2):179-89. DOI: 10.1016/s0169-328x(03)00318-8. View